+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Atrial Fibrillation Market [By Devices; By End-Users; By Region] Market Outlook 2027

  • ID: 5131080
  • Report
  • July 2020
  • Region: Global
  • 108 Pages
  • Rockville Research
1 of 4
The Global Atrial Fibrillation Market is Estimated to be Valued at US$ 16 Billion in the Year 2027

FEATURED COMPANIES

  • Biosense Webster, Inc
  • Biotronik SE & Co. KG
  • Koninklijke Philips N.V.
  • Medtronic, Inc.
  • MORE

Industry Insights

According to this new report, the global atrial fibrillation market is estimated to be valued at US$ 16 Billion in the year 2027, growing at a CAGR of 11.5% in the period 2020 to 2027. Growth of the market is driven by the prevalence of atrial fibrillation cases and cardiac disorders, a rise in the number of hypertension patients, growth in the geriatric population, and increasing demand for minimally invasive procedures.

Atrial fibrillation (AF) is a type of cardiac arrhythmia characterized by irregular electrical activities in the atria. It is the most common form of cardiac arrhythmia. The condition is classified into three categories: paroxysmal, persistent, and permanent atrial fibrillation. Treatment of AF is dependent on the duration and severity of the underlying symptoms.

Technological advancement in cardiac imaging has led to substantial enhancement of the efficacy of atrial fibrillation ablation. Advanced cardiac imaging is expected to bring about improved catheter AF ablation outcomes by risk stratification and early detection of cerebral emboli with pre-procedural use of 3D printed models.

Report Scope

This report “Global Atrial Fibrillation Market [(By Devices - EP Ablation Catheter, EP Diagnostic Catheter, Cardiac Monitors, Mapping/Navigation/Recording & Access Devices; By End-Users - Hospitals, Ambulatory Surgical Centres & Cardiac Centres; By Region - North America (The US), Asia Pacific (Japan & India) & Europe (The UK & Germany)] Market Outlook 2027” provides detailed analysis of the global atrial fibrillation market from qualitative and quantitative outlooks during the forecast period across various market segments and regional markets. It also provides coverage on market dynamics with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Parameter Description

  • Base year: 2017
  • Forecast period: 2020 - 2027
  • Market sizing: Revenue in US$ Billions & CAGR for the period 2016 to 2027
  • Country Analysis: The US, The UK, Germany, India & Japan
  • Vendor scope: Biosense Webster, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Boston Scientific Corporation, Medtronic, Inc., Biotronik SE & Co. KG & Koninklijke Philips N.V.
  • Report coverage: Revenue forecast, market share analysis, company analysis, competitive landscape, market growth drivers, market restraints, market trends, and company profiles

Segments Covered

The report provides revenue forecasts for global, regional, and country levels. It also provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. For the purpose of research, the publisher has segmented the global atrial fibrillation market reports on the basis of geography and market segments.

Device Type Outlook, Revenue (2018 - 2027E, US$ Billions)

  • EP Ablation Catheter
  • EP Diagnostic Catheter
  • Cardiac Monitors
  • Mapping/Navigation/Recording
  • Access Devices

End-User Outlook, Revenue (2018 - 2027E, US$ Billions)

  • Hospitals
  • Ambulatory Surgical Centres
  • Cardiac Centres

Regional Outlook, Revenue (2017 - 2027E, US$ Billions)

  • North America
  • Europe
  • Asia Pacific

Country Outlook, Revenue (2017 - 2027E, US$ Billions)

  • The US
  • The UK
  • Germany
  • Japan
  • India

Vendors Outlook, Revenue (2016 - 2019, US$ Billions)

  • Biosense Webster, Inc.
  • St. Jude Medical, Inc. (Abbott Laboratories)
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Medtronic, Inc.
  • Koninklijke Philips N.V.

Target Audience

  • Device Manufacturers
  • Drug Manufacturers
  • End Users
  • Research Professionals
  • Healthcare Consultancies
  • Regulatory Bodies

Key Questions Answered in the Report

  • The historical market size of the atrial fibrillation market from 2017 to 2019 in US$ Billions.
  • Projected market growth in the forecasted period 2020 to 2027 with estimated revenue for each year in US$ Billions.
  • The regional analysis of the atrial fibrillation market is provided for the period 2019 to 2027.
  • Market drivers, restraints, and industry trends that have an impact on revenue.
  • Profiling of major companies with a detailed analysis of their atrial fibrillation devices.

Customization

The publisher provides customization of the study in order to provide specific information as sought by the client. 

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Biosense Webster, Inc
  • Biotronik SE & Co. KG
  • Koninklijke Philips N.V.
  • Medtronic, Inc.
  • MORE

1. Executive Summary

2. Research Methodology

3. Cardiac Arrhythmia
3.1 Overview
3.2 Types
3.3 Treatment
3.3.1 Pharmacological
3.3.2 Non-Pharmacological
3.4 Market Analysis
3.4.1 Market Sizing (Actual & Forecasted)
3.4.2 Market Share by Region
3.4.3 Market Share by End-Users

4. Electrophysiology
4.1 Overview
4.2 Procedure
4.2.1 Ventricular Tachycardia
4.2.2 Atrial Fibrillation
4.2.3 General Mapping and Ablations

5. Atrial Fibrillation
5.1 Overview
5.2 Classification
5.3 Treatment

6. Market Analysis
6.1 Market Sizing (Actual & Forecasted)
6.2 Market Share Analysis
6.2.1 Market Share by Segment
6.2.2 Market Share by Surgical Procedure Type
6.2.3 Market Share by Region
6.2.4 Market share by End-User

7. Market Segmentation
7.1 By Devices
7.1.1 EP Ablation Catheter
7.1.1.1 Overview
7.1.1.2 Market Sizing (Actual & Forecasted)
7.1.2 EP Diagnostic Catheter
7.1.2.1 Overview
7.1.2.2 Market Sizing (Actual & Forecasted)
7.1.3 Cardiac Monitors
7.1.3.1 Overview
7.1.3.2 Market Sizing (Actual & Forecasted)
7.1.4 Mapping/Navigation/Recording
7.1.4.1 Overview
7.1.4.2 Market Sizing (Actual & Forecasted)
7.1.5 Access Devices
7.1.5.1 Overview
7.1.5.2 Market Sizing (Actual & Forecasted)
7.2 By End-Users
7.2.1 Hospitals
7.2.1.1 Market Sizing (Actual & Forecasted)
7.2.2 Cardiac Centers
7.2.2.1 Market Sizing (Actual & Forecasted)
7.2.3 Ambulatory Surgical Centers
7.2.3.1 Market Sizing (Actual & Forecasted)

8. Regional Analysis
8.1 North America
8.1.1 Market Sizing (Actual & Forecasted)
8.1.2 Market Share by Application
8.1.3 The US
8.1.3.1 Market Sizing (Actual & Forecasted)
8.2 Asia Pacific
8.2.1 Market Sizing (Actual & Forecasted)
8.2.2 Market Share by Application
8.2.3 Japan
8.2.3.1 Market Sizing (Actual & Forecasted)
8.2.4 India
8.2.4.1 Market Sizing (Actual & Forecasted)
8.3 Europe
8.3.1 Market Sizing (Actual & Forecasted)
8.3.2 Market Share by Application
8.3.3 Germany
8.3.3.1 Market Sizing (Actual & Forecasted)
8.3.3.2 Market Share by Product
8.3.4 The UK
8.3.4.1 Market Sizing (Actual & Forecasted)

9. Market Dynamics
9.1 Industry Trends & Developments
9.1.1 Adoption of Pulse Field Ablation Technologies
9.1.2 Adoption of Enhanced Imaging Techniques
9.1.3 Mergers & Acquisitions
9.1.4 Technological Advancement
9.2 Growth Drivers
9.2.1 Prevalence of Atrial Fibrillation
9.2.2 Increasing Incidences of Cardiac Disorders
9.2.3 Rise in Number of Hypertension Patients
9.2.4 Growing Geriatric Population
9.2.5 Increasing Demand for Minimally Invasive Procedures
9.3 Challenges
9.3.1 Stringent Regulatory Approvals
9.3.2 Dearth of Skilled Professionals
9.3.3 Higher Preference to Drugs
9.3.4 High Cost of AF Devices

10. Competitive Landscape
10.1 Market Share Analysis
10.2 Product Landscape
10.3 Therapeutic Pipeline
10.4 Financial Analysis

11. Company Profile
11.1 Biosense Webster, Inc.
11.2 St. Jude Medical, Inc. (Abbott Laboratories)
11.3 Medtronic, Inc.
11.4 Boston Scientific Corporation
11.5 Biotronik SE & Co. KG
11.6 Koninklijke Philips N.V.

List of Tables and Figures
Figure 1: Research Methodology
Table 1: Analysis of Various Types of Arrhythmias
Figure 2: Global Cardiac Arrhythmia Monitoring Devices Market Size by Value, 2018-27E (US$ Billions)
Figure 3: Global Cardiac Arrhythmia Monitoring Devices Market Share by Region (2019)
Figure 4: Global Cardiac Arrhythmia Monitoring Devices Market Share by End-Users (2019)
Figure 5: Progression of Atrial Fibrillation by Stage
Figure 6: Atrial Fibrillation Market Classification by Devices
Figure 7: Atrial Fibrillation Treatment Paradigm
Table 2: Antiarrhythmic Drug Therapy for Sinus Rhythm
Figure 8: Global Atrial Fibrillation Market Size by Value, 2017-27E (US$ Billions)
Figure 9: Incidence Rates of Atrial Fibrillation & Flutter (per 100,000) by Nations (2019)
Figure 10: Global Atrial Fibrillation Market Share by Segment (2019)
Figure 11: Global Atrial Fibrillation Market Share by Surgical Procedure Type (2019)
Figure 12: Global Atrial Fibrillation Market Share by Region (2019)
Figure 13: Global Atrial Fibrillation Market Share by End-User (2019)
Figure 14: Global Atrial Fibrillation devices - EP Ablation Catheter Market Size by Value, 2018-27E (US$ Billion)
Figure 15: Global Atrial Fibrillation devices - EP Diagnostic Catheter Market Size by Value, 2018-27E (US$ Billion)
Figure 16: Global Atrial Fibrillation devices - Cardiac Monitors Market Size by Value, 2018-27E (US$ Billion)
Figure 17: Global Atrial Fibrillation devices - Mapping/Navigation/Recording Market Size by Value, 2018-27E (US$ Billion)
Figure 18: Global Atrial Fibrillation devices - Access Devices Market Size by Value, 2018-27E (US$ Billion)
Figure 19: Global Atrial Fibrillation Market End-Users - Hospitals Market Size by Value, 2018-27E (US$ Billion)
Figure 20: Global Atrial Fibrillation Market End-Users - Cardiac Centers Market Size by Value, 2018-27E (US$ Billion)
Figure 21: Global Atrial Fibrillation Market End-Users - Ambulatory Surgical Centers Market Size by Value, 2018-27E (US$ Billion)
Figure 22: North America Atrial Fibrillation Market Size by Value, 2017-27E (US$ Billions
Figure 23: North America Atrial Fibrillation Market Share by Application (2019)
Figure 24: Incidences of Atrial Fibrillation in the US, 2010-50E (Millions)
Figure 25: The US Atrial Fibrillation Market Size by Value, 2017-27E (US$ Billions)
Figure 26: Asia Pacific Atrial Fibrillation Market Size by Value, 2017-27E (US$ Billions)
Figure 27: Asia Pacific Atrial Fibrillation Market Share by Application (2019)
Figure 28: Japan Atrial Fibrillation Market Size by Value, 2017-27E (US$ Billions)
Figure 29: India Atrial Fibrillation Market Size by Value, 2017-27E (US$ Billions)
Figure 30: Europe Atrial Fibrillation Market Size by Value, 2017-27E (US$ Billions)
Figure 31: Europe Atrial Fibrillation Market Share by Application (2019)
Figure 32: Germany Atrial Fibrillation Market Size by Value, 2017-27E (US$ Billions)
Figure 33: Germany Atrial Fibrillation Market Share by Product (2019)
Figure 34: The UK Atrial Fibrillation Market Size by Value, 2017-27E (US$ Billions)
Table 3: Mergers & Acquisitions in Atrial Fibrillation Market
Figure 35: Global Atrial Fibrillation Incidences, 2005-2050E (Millions)
Table 4: Incidences of Cardiac Disorders
Figure 36: Global Hypertension Patients Numbers, 2015-19 (Billions)
Figure 37: Global Ageing (Aged above 65 years) Population, 2013-20E (Millions)
Figure 38: Age-related Prevalence of Atrial Fibrillation (Thousands)
Figure 39: Global Atrial Fibrillation Devices Market Share by Companies (2019)
Table 5: Global Atrial Fibrillation Devices Market Competitive Landscape
Table 6: Global Electrophysiology Ablation Energy Sources by Key Competitors
Table 7: Global Electrophysiology Market - Independent Companies Analysis
Figure 40: Top Selling Products of Atrial Fibrillation, 2016-22E (Units)
Figure 41: Global Atrial Fibrillation Products Forecasted Revenue Analysis, 2016-23 (US$ Millions)
Table 8: Global Atrial Fibrillation Devices Manufacturers Revenue Comparison, FY2018-FY2022E (US$ Billions)
Table 9: Global Atrial Fibrillation Devices Manufacturers Financial Analysis (FY2020E)
Figure 42: Johnson & Johnson Medical Devices Market Share by Segment (FY2019)
Figure 43: Johnson & Johnson Medical Devices Net Sales, FY2016-FY2019 (US$ Billions)
Figure 44: Abbott Laboratories Revenue by Business Segment (FY2019)
Figure 45: Abbott Laboratories Net Sales, FY2016-FY2019 (US$ Billions)
Figure 46: Medtronic, Inc. Revenue by Business Segment (FY2019)
Figure 47: Medtronic, Inc. Net Sales, FY2016-FY2019 (US$ Billions)
Figure 48: Boston Scientific Corporation Revenue by Business Segment (FY2019)
Figure 49: Boston Scientific Corporation Net Sales, FY2016-FY2019 (US$ Billions)
Figure 50: Biotronik SE & Co. KG Revenue by Business Segment (FY2019)
Figure 51: Biotronik SE & Co. KG Net Sales, FY2016-FY2019 (US$ Billions)
Figure 52: Koninklijke Philips N.V. Revenue by Business Segment (FY2019)
Figure 53: Koninklijke Philips N.V. Net Sales, FY2016-FY2019 (US$ Billions)

Note: Product cover images may vary from those shown
3 of 4

FEATURED COMPANIES

  • Biosense Webster, Inc
  • Biotronik SE & Co. KG
  • Koninklijke Philips N.V.
  • Medtronic, Inc.
  • MORE

Cardiac arrhythmia refers to a group of conditions that causes irregular heartbeat also known as a flutter or fibrillation. There are several categories of arrhythmia such as bradycardia (slow heartbeat), tachycardia (fast heartbeat). Atrial Fibrillation (AF) is one of the most common sustained cardiac arrhythmia which causes the atria to contract abnormally. It is characterized by loss of the normal electrical rhythm of the heart. AF is classified into three categories: paroxysmal, persistent, and permanent atrial fibrillation. The treatment paradigm of AF is based upon symptoms and severity of the condition. Atrial Fibrillation market by devices is segmented into EP Ablation Catheters, EP Diagnostic Catheters, Cardiac Monitors, EP Mapping and Recording Systems, Access, ICE/Others, and LAA Closure. EP Ablation Catheter is the largest and fastest-growing segment of the EP market.

The global atrial fibrillation market is expected to witness strong growth due to the rise in cardiac ailments and technological advancements in the industry. Growth of the global atrial fibrillation market is primarily attributed to factors such as the higher prevalence of atrial fibrillation cases and cardiac disorders, a rise in the number of hypertension patients, a growing geriatric population, and increasing demand for a minimally invasive procedure. However, the market faces challenges due to stringent regulatory approval, the dearth of skilled professionals, the high cost of devices, and a higher preference for AF drugs.

The report “Global Atrial Fibrillation Market [(By Devices - EP Ablation Catheter, EP Diagnostic Catheter, Cardiac Monitors, Mapping/Navigation/Recording & Access Devices; By End-Users - Hospitals, Ambulatory Surgical Centres & Cardiac Centres; By Region - North America (The US), Asia Pacific (Japan & India) & Europe (The UK & Germany)] Market Outlook 2027” provides an in-depth analysis of the current scenario, detailed market outlook of the global atrial fibrillation market. The market is segmented by devices and end-users. Future forecasts of atrial fibrillation market overall and across various market segments have been provided in the report till 2027. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global atrial fibrillation ablation market include Biosense Webster, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Medtronic, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG &
Koninklijke Philips N.V., among others. These players are profiled herein based on attributes such as business overview, product segments, and financial analysis. It also compiles the performance comparison of the aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in the global electrophysiology/atrial fibrillation ablation market.

Note: Product cover images may vary from those shown
4 of 4
  • Biosense Webster, Inc
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Medtronic, Inc.
  • St. Jude Medical, Inc. (Abbott Laboratories)
Note: Product cover images may vary from those shown
Adroll
adroll